Profesor Titular asociado de Medicina Interna




descargar 0.97 Mb.
títuloProfesor Titular asociado de Medicina Interna
página15/15
fecha de publicación14.08.2016
tamaño0.97 Mb.
tipoDocumentos
med.se-todo.com > Química > Documentos
1   ...   7   8   9   10   11   12   13   14   15

13- Daly MP. Anemia in the elderly. Am Fam Physician 1989;39:129-36.

14- Elis A, Ravid M, Manor Y, Bental T, Lishner M. A clinical approach to 'idiopathic' normocytic-normochromic anemia? J Am Geriatr Soc 1996;44:832-4.

15- Lipschitz DA. The anemia of chronic disease. J Am Geriatr Soc 1990;38:1258-64.

16- Shine JW. Microcytic anemia. Am Fam Physician 1997;55:2455-62.

17- Gordon SR, Smith RE, Power GC. The role of endoscopy in the evaluation of iron deficiency anemia in patients over the age of 50. Am J Gastroenterol 1994;89:1963-7.

18- Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med 1993;329:1691-5.

19- Joosten E, Ghesquiere B, Linthoudt H, Krekelberghs F, Dejaeger E, Boonen S, et al. Upper and lower gastrointestinal evaluation of elderly inpatients who are iron deficient. Am J Med 1999;107:24-9.

20- Gordon S, Bensen S, Smith R. Long-term follow-up of older patients with iron deficiency anemia after a negative GI evaluation. Am J Gastroenterol 1996; 91:885-9.

21- Stabler SP. Vitamin B12 deficiency in older people: improving diagnosis and preventing disability [Editorial]. J Am Geriatr Soc 1998;46:1317-9.

22- Nexo E, Hansen M, Rasmussen K, Lindgren A, Grasbeck R. How to diagnose cobalamin deficiency. Scand J Clin Lab Invest 1994;219:61-76.

23- Kuzminski AM, Del Giacco EJ, Allen RH, Stabler SP, Lindenbaum J. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92: 1191-8.

24- Sumner AE, Chin MM, Abrahm JL, Berry GT, Gracely EJ, Allen RH, et al. Elevated methylmalonic acid and total homocysteine levels show high prevalence of vitamin B12 deficiency after gastric surery. Ann Intern Med 1996;124:469-76.

25- Davenport J. Macrocytic anemia. Am Fam Physician 1996;53:155-62.

26- Marchand A, Galen S, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980;243:1909-11.

27- Tabbara IA. Hemolytic anemias. Diagnosis and management. Med Clin North Am 1992;76:649-68.

28- Ucar K. Clinical presentation and management of hemolytic anemias. Oncology [Huntingt] 2002;16(9 suppl 10):163-70.

29- Engelfriet CP, Overbeeke MA, von dem Borne AE. Autoimmune hemolytic anemia. Semin Hematol 1992;29:3-12.

30- Jefferies LC. Transfusion therapy in autoimmune hemolytic anemia. Hematol Oncol Clin North Am 1994;8:1087-104.

31- Schwartz RS, Berkman EM, Silberstein LE. Autoimmune hemolytic anemias. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., eds. Hematology: basic principles and practice. 3d ed. Philadelphia: Churchill Livingstone, 2000:624.

32- Saif MW. HIV-associated autoimmune hemolytic anemia: an update. AIDS Patient Care STDS 2001;15:217-24.

33- Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.

34- Petz LD. Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 1993;7:242-54.

35- Schrier SL. Extrinsic nonimmune hemolytic anemias. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, et al., eds. Hematology: basic principles and practice. 3d ed. Philadelphia: Churchill Livingstone, 2000:630-8.

36- Berkowitz FE. Hemolysis and infection: categories and mechanisms of their interrelationship. Rev Infect Dis 1991;13:1151-62.

37- Beutler E, Luzzatto L. Hemolytic anemia. Semin Hematol 1999;36(4 suppl 7):38-47.

38- George ED, Sadovsky R. Multiple myeloma: recognition and management. Am Fam Physician 1999;59:1885-94.
39- Dispenzieri A, Gertz MA, Therneau TM, Kyle RA. Retrospective cohort study of 148 patients with polyclonal gammopathy. Mayo Clin Proc 2001;76:476-87.
40- Alexanian R, Weber D, Liu F. Differential diagnosis of monoclonal gammopathies. Arch Pathol Lab Med 1999;123:108-13.
41- Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proc 2003;78:21-33.
42- Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N Engl J Med 2002;346:564-9.

43- Kyle RA. Multiple myeloma: how did it begin? Mayo Clin Proc 1994;69:680-3.

44- Riccardi A, Gobbi P, Ucci G, Bertoloni D, Luoni R, Rutigliano L, et al. Changing clinical presentation of multiple myeloma. Eur J Cancer 1991;27:1401-5.

45- Boccadoro M, Pileri A. Diagnosis, prognosis, and standard treatment of multiple myeloma. Hematol Oncol Clin North Am 1997;11:111-31.

46- Saadeh C. The erythrocyte sedimentation rate: old and new clinical applications. South Med J 1998; 3:220-5.

47- Brigden M. The erythrocyte sedimentation rate: still a helpful test when used judiciously. Postgrad Med 1998;103:257-74.

48- Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 1986;104:515-23.

49- Katz PR, Karuza J, Gutman SI, Bartholomew W, Richman G. A comparison between erythrocyte sedimentation rate (ESR) and selected acute-phase proteins in the elderly. Am J Clin Pathol 1990; 94:637-40.

50- Weinstein A, Del Giudice J. The erythrocyte sedimentation rate: time honored and tradition bound [Editorial]. J Rheumatol 1994;21:1177-8.

51- Smith EM, Samadian S. Use of the erythrocyte sedimentation rate in the elderly. Br J Hosp Med 1994;51:394-7.

52- Tinetti ME, Schmidt A, Baum J. Use of the erythrocyte sedimentation rate in chronically ill, elderly patients with a decline in health status. Am J Med 1986;80:844-8.

53- Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med 1986;146:1581-3.

54- Lluberas-Acosta G, Schumacher HR Jr. Markedly elevated erythrocyte sedimentation rates: consideration of clinical implications in a hospital population. Br J Clin Pract 1996;50:138-42.

55- Sox HC Jr, Liang MH. The erythrocyte sedimentation rate: guidelines for rational use. Ann Intern Med 1986;104:515-23.

56- Bottiger LE, Svedberg CA. Normal erythrocyte sedimentation rate and age. Br Med J 1967;2:85-7.

57- Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol 1994;21:1227-37.

58- Stuart J, Whicher JT. Tests for detecting and monitoring the acute phase response. Arch Dis Child 1988;63:115-7.

59- Katz PR, Karuza J, Gutman SI, Bartholomew W, Richman G. A comparison between erythrocyte sedimentation rate (ESR) and selected acute-phase proteins in the elderly. Am J Clin Pathol 1990; 94:637-40.

60- Tinetti ME, Schmidt A, Baum J. Use of the erythrocyte sedimentation rate in chronically ill, elderly patients with a decline in health status. Am J Med 1986;80:844-8.

61- Fincher RM, Page MI. Clinical significance of extreme elevation of the erythrocyte sedimentation rate. Arch Intern Med 1986;146:1581-3.

62- Allhiser JN, McKnight TA, Shank JC. Lymphadenopathy in a family practice. J Fam Pract 1981;12: 27-32.

63- Williamson HA Jr. Lymphadenopathy in a family practice: a descriptive study of 249 cases. J Fam Pract 1985;20:449-58.

64- Fijten GH, Blijham GH. Unexplained lymphadenopathy in family practice. An evaluation of the probability of malignant causes and the effectiveness of physicians' workup. J Fam Pract 1988;27: 373-6.

65- Pangalis GA, Vassilakopoulos TP, Boussiotis VA, Fessas P. Clinical approach to lymphadenopathy. Semin Oncol 1993;20:570-82.

66- Slap GB, Brooks JS, Schwartz JS. When to perform biopsies of enlarged peripheral lymph nodes in young patients. JAMA 1984;252:1321-6.

67- Cines DB, Blanchette VS Immune thrombocytopenic purpura in N Engl J Med 346, 13, 2002, 995-. 1008.

68- George JN Thrombotic Thrombocytopenic purpura in N. Engl J. Med 354, 18, 2006, 1927-35

69- Bainton R, Makris M The diagnosis and management of acquired haemophilia. CME Bulletin Haematology 2000, vol 3, 1, 3-5.

70- Razzaq Samiya , Hemolytic uremic syndrome: an emerging health risk Am Family Phisician 2006, 74, 991-6

71- Sallah Sabat, Bobzien William Bleeding problems in patients with liver disease Postgrad Med 1999, 106 : 187-95.

72- Suárez Amaranto, Sindrome de lisis tumoral, Revista colombiana de cancerologia, 2004, 8, 31-39

73- Stuart BJ, USNR MC y col Polycythemia vera Am Fam Physician 2004, 69, 2139-44.

74- Levine Js, Branch DW, Rauch J The antiphospholipid syndrome N Engl J Med 2000, 346, 752

75- Brandhagen DJ, Fairbanks VF Recognition and management of Hereditary haemocromatosis Am Fam. Physician 2002, 65; 5, 853-860.

76- Yusen R y col Trastornos de la hemostasia y trombosis en Manual Washington de Terapeutica Médica Ed: Cooper DH y col. 2007, Madrid, 414-444.

77- Blinder M y col Anemia y hemoterapia en Manual Washington de Terapeutica Médica Ed: Cooper DH y col. 2007, Madrid, 445-462.




1   ...   7   8   9   10   11   12   13   14   15

similar:

Profesor Titular asociado de Medicina Interna iconProfesor Titular asociado de Medicina Interna

Profesor Titular asociado de Medicina Interna iconProfesor Titular asociado de Medicina Interna

Profesor Titular asociado de Medicina Interna iconProfesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira

Profesor Titular asociado de Medicina Interna iconPhd profesor Titular Universidad Libre Seccional Pereira


Medicina



Todos los derechos reservados. Copyright © 2015
contactos
med.se-todo.com